Evidence map›Paper›PMID 32512914›Full record

ArticleInternational journal of molecular sciences2020

A Novel Approach to Optimize Hot Melt Impregnation in Terms of Amorphization Efficiency.

Kamil Garbera, Krzesimir Ciura, Wiesław Sawicki

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.1field-weighted citation impact, top 66% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Kamil GarberaFormulation Department, Tarchomin Pharmaceutical Works "Polfa" S.A., Fleminga 2, 03-176 Warszawa, Poland.
Krzesimir CiuraDepartment of Physical Chemistry, Medical University of Gdańsk, Hallera 107, 80-416 Gdańsk, Poland.
Wiesław SawickiDepartment of Physical Chemistry, Medical University of Gdańsk, Hallera 107, 80-416 Gdańsk, Poland.
Gdańsk Medical University · PL

Funding

the Ministry of Science and Higher Education ST3 02-0003/07/518
6 · The paper itself

Abstract

In this study, an innovative methodology to optimize amorphization during the hot melt impregnation (HMI) process was proposed. The novelty of this report revolves around the use of thermal analysis in combination with design of experiments (DoEs) to reduce residual crystallinity during the HMI process. As a model formulation, a mixture of ibuprofen (IBU) and Neusilin was used. The main aim of the study was to identify the critical process parameters of HMI and determine their optimal values to assure a robust impregnation process and possibly the highest possible amorphization rate of IBU. In order to realize this, a DoE approach was proposed based on a face-centered composite design involving three factors. The IBU/Neusilin ratio, the feeding rate, and the screw speed were considered as variables, while the residual crystallinity level of IBU, determined using differential scanning calorimetry (DSC), was measured as the response. Additionally, the stability of IBU under HMI was analyzed using high-performance liquid chromatography to estimate the extent of potential degradation. In order to verify the correctness of the DoE model, tested extrudates were manufactured by HMI and the obtained extrudates were thoroughly examined using scanning electron micrography, X-ray powder diffraction, and DSC.

Indexed as

Calorimetry, Differential ScanningChemistry, PharmaceuticalChromatography, High Pressure LiquidHot Melt Extrusion TechnologyIbuprofenPharmaceutic AidsTabletsX-Ray DiffractionIbuprofenPharmaceutic AidsTabletsamorphizationdesign of experimentshot melt impregnationibuprofen

Identifiers

PMID32512914
PMCPMC7312772
OpenAlexW3032998879

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.